Aurora B kinase phosphorylates and instigates degradation of p53

Chris P Gully1, Guermarie Velazquez-Torres, Ji-Hyun Shin

  • 1Graduate School of Biomedical Sciences, University of Texas, Houston, TX 77030, USA.

Insights

Aurora B kinase phosphorylates tumor suppressor p53, accelerating its degradation and suppressing its cell cycle inhibition. Inhibiting Aurora B restores p53 function, offering a potential cancer therapy strategy.

Area of Science:

  • Cell Biology
  • Molecular Oncology
  • Biochemistry

Background:

  • Aurora B kinase is crucial for cell division and frequently overexpressed in cancers.
  • Tumor suppressor p53 regulates the cell cycle and apoptosis.
  • The relationship between Aurora B and p53 during the cell cycle was previously unknown.

Purpose of the Study:

  • To investigate the interaction and regulation between Aurora B kinase and p53.
  • To elucidate the mechanism by which Aurora B affects p53 function.
  • To explore the therapeutic potential of targeting Aurora B in cancer cells with wild-type p53.

Main Methods:

  • Co-immunoprecipitation to detect protein interactions.
  • Western blotting to assess protein levels and phosphorylation.
  • Ubiquitination assays to study protein degradation pathways.
  • Cell-based assays to evaluate gene expression and cell proliferation.

Main Results:

  • Aurora B directly interacts with p53 in the nucleus and at centromeres.
  • Aurora B phosphorylates p53 at specific sites (S183, T211, S215), promoting its degradation via the ubiquitin-proteasome system.
  • This phosphorylation suppresses the expression of p53 target genes involved in cell cycle arrest and apoptosis (e.g., p21, PUMA).
  • Inhibition of Aurora B in cancer cells with wild-type p53 increased p53 levels and its target gene expression, leading to tumor growth inhibition.

Conclusions:

  • Aurora B directly regulates p53 stability and function by promoting its degradation.
  • Overexpression of Aurora B can inactivate the tumor suppressor function of p53.
  • Targeting Aurora B kinase is a promising therapeutic strategy for cancers with wild-type p53.

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
DNA Damage Can Stall the Cell Cycle02:36

DNA Damage Can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
DNA Damage can Stall the Cell Cycle02:36

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
Anaphase Promoting Complex00:50

Anaphase Promoting Complex

The stepwise destruction of specific proteins is necessary for the progression and completion of the cell cycle. Such proteins are ubiquitinated by ubiquitin ligases and then subsequently destroyed by the proteasome. The SCF (Skp1/Cullin/F-box) and the anaphase-promoting complex (APC) are two important ubiquitin ligases involved in cell cycle progression. While SCF is active throughout the cell cycle, APC gets activated during metaphase to anaphase transition. Cdc20 or Cdh1 binds to APC and...